Amylin gene expression mediated by cAMP/PKA and transcription factors HNF-1 and NFY

Molecular and Cellular Endocrinology

Volumn 210, Issue 1-2, 2003, Pages 63-75

  Cluck, Michael W ^a   Murphy, Leon O ^c   Olson, Jody ^d   Knezetic, Joseph A ^d   Adrian, Thomas E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amylin; HNF 1; mRNA; NFY; Transcription

Indexed keywords

AMYLIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INSULIN; ISOBUTYLMETHYLXANTHINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NUCLEAR FACTOR Y; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HNF 1; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL LINE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN SECRETION;

EID: 0242663404     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.08.005     Document Type: Article

References (62)

1. Alam T., Chen L., Ogawa A., Leffert J., Unger R., Luskey K. Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting. Diabetes. 41:1992;508-514.
2. Asfari M., Janjic D., Meda P., Li G., Hallan P.A., Wollheim C.B. Establishment of 2-mercaptoethanol-dependant differentiated insulin-secreting cell lines. Endocrinology. 130:1992;167-178.
3. Bach I., Yaniv M. More potent transcriptional activators or a transdominant inhibitor of the HNF-1 homeoprotein family are generated by alternative RNA processing. EMBO J. 12:1993;4229-4242.
4. Blumenfeld M., Maury M., Chouard T., Yaniv M., Condamine H. Hepatocyte nuclear factor 1 (HNF1) shows a wider distribution than product of its known target genes in developing mouse. Development. 113:1991;589-599.
5. Carty M.D., Lillquist J.S., Peshavaria M., Stein R., Soeller W.C. Identification of cis and trans active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta cells. J. Biol. Chem. 272:1997;11986-11993.
6. Chinery B., Brockman J.A., Dransfield D.T., Coffey R.J. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein β J. Biol. Chem. 272:1997;30356-30361.
7. Cordell B., Bell G., Tischer E., DeNoto F.M., Ullrich A., Pictet R., Rutter W.J., Goodman H.M. Isolation and characterization of a cloned rat insulin gene. Cell. 18:1979;533-543.
8. Currie R.A. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J. Biol. Chem. 273:1998;1430-1434.
9. DeWit L., Van Mansfeld A., Van Teeffelen H., Lips C., Hoppener J. Strong promoter activity of human and rat islet amyloid polypeptide/amylin gene constructs in mouse beta cells (BTC 3). Bioch. Biophys. Res. Commun. 192:1993;840-848.
10. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11:1983;1475-1489.
11. Ding W.Q., Holicky E., Miller L.J. Glucose and forskolin regulate IAPP gene expression through different signal transduction pathways. Am. J. Physiol. Endocrinol. Met. 281(5):2001;E938-E945.
12. Emens L.A., Landers D.W., Moss L.G. Hepatocyte nuclear factor 1a is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7300-7304.
13. Enoki S., Mitsukawa T., Takemura J., Nakazato M., Aburaya J., Toshimori H., Matsukara S. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 15:1992;97-102.
14. Foulkes, N.S., Sassone-Corsi, P., 1996. Transcription factors coupled to the cAMP-signaling pathway. BBA-Reviews on Cancer. 1288 (3), http://www.elsevier.com .
15. Furnsinn C., Leuvenink H., Roden M., Nowotny P., Schneider B., Rohac M., Pieber T., Clodi M., Waldhausl W. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 267:1994;E300-E305.
16. Galsgaard E.D., Gouilleux F., Groner B., Serup P., Nielsen J.H., Billestrup N. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol. Endocrinol. 10:1996;652-660.
17. Gasa R., Gomis R., Casamitjana R., Rivera F., Novials A. Glucose regulation of islet amyloid polypeptide gene expression in rat pancreatic islets. Am. J. Physiol. 272:1997;E543-E549.
18. German M., Moss L., Wang J., Ruter W. The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical B-cell nuclear complexes. Mol. Cell. Biol. 12:1992;1777-1788.
19. Gregori C., Kahn A., Pichard A.L. Competition between transcription factors HNF1 and HNF3, an alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase promoter. Nucl. Acids Res. 21:1993;897-903.
20. Jonsson J., Carlsson L., Edlund T., Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 371:1994;606-609.
21. Karlsson O., Walker M.D., Rutter W.J., Edlund T. Individual protein binding domains of the insulin gene enhancer positively activate beta cell specific transcription. Mol. Cell. Biol. 9:1989;823-827.
22. Karlsson O., Thor S., Norberg T., Ohlsson H., Edlund T. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo and a cys-his domain. Nature. 344:1990;879-882.
23. Kautzky-Willer A., Thomaseth K., Pacini G., Clodi M., Ludvik B., Streli C., Waldhausl W., Prager R. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia. 37:1994;188-194.
24. Knezetic J.A., Felsenfeld G. Identification and characterization of a chicken alpha-globin enhancer. Mol Cell Biol. 9:1989;893-901.
25. Koranyi L., James D.E., Kraegen E.W., Permutt M.A. Feedback inhibition of insulin gene expression by insulin. J. Clin. Invest. 89:1992;432-436.
26. Leonard J., Serup P., Gonzalez G., Edlund T., Montminy M. The LIM family transcription factor Isl 1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6247-6251.
27. Lomedico P., Rosenthal N., Efstratidadis A., Gilbert W., Kolodner R., Tizard R. The structure and evolution of the two nonallelic rat preproinsulin genes. Cell. 18:1979;545-558.
28. Lorenzo A., Razzaboni B., Weir G., Yankner B. Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus. Nature. 368:1994;756-760.
29. Lu M., Seufert J., Habener J.F. Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β J. Biol. Chem. 272:1997;28349-28359.
30. Lukinius A., Wilander E., Westermark G., Engsstrom U., Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of human pancreatic islets. Diabetologia. 32:1989;240-244.
31. Maity S.N., Golumbek P.T., Karsenty G., DeCrombrugghe B. Selective activation of transcription by a novel CCAAT binding factor. Science. 241:1988;582-585.
32. Marshak S., Totary H., Cerasu E., Melloul D. Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;15057-15062.
33. Mendel D.B., Hansen L.P., Graves M.K., Conley P.B., Crabtree G.R. HNF-1a and HNF-1b (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5:1991;1042-1056.
34. Meredith M., Rabaglia M.E., Corbett J.A., Metz S. Dual functional effects of interleukin-1B on pure nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes. 45:1996;1783-1791.
35. Milos P.M., Zaret K.S. A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev. 6:1992;991-1004.
36. Mirzabekov T.A., Lin M.C., Kagan B.L. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271:1996;1988-1992.
37. Mulder H., Ahren B., Sundler F. Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats. Am. J. Physiol. 271:1996;E1008-E1014.
38. Mulder H., Ahren B., Sundler F. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin induced diabetes in rats. J. Endocrinol. 152:1997;495-501.
39. Oetjen E., Diedrich T., Eggers A., Eckert B., Knepel W. Distinct properties of the cAMP responsive element of the rat insulin I gene. J. Biol. Chem. 269:1994;27036-27044.
40. Ohlsson H., Karlsson O., Edlund T. A beta cell specific protein binds to the two major regulatory sequences of the insulin gene enhancer. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4228-4231.
41. Ohlsson H., Thor S., Edlund T. Novel insulin promoter and enhancer binding proteins that discriminate between pancreatic A and B cells. Mol. Endocrinol. 5:1991;897-904.
42. Ohlsson H., Karlsson K., Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 12:1993;4251-4259.
43. Osawa H., Robey R.B., Printz R.L., Granner D.K. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene. J. Biol. Chem. 271:1996;17296-17303.
44. Peers B., Leonard J., Sharma S., Teitelman G., Montminy M.R. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF 1. Mol. Endocrinol. 8:1994;1798-1806.
45. Permert J., Larsson J., Westermark G., Herrington M., Christmanson L., Pour P., Westermmark P., Adrian T.E. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Eng. J. Med. 330:1994;313-318.
46. Philippe J., Missotten M. Functional characterization of a cAMP-response element of the rat insulin I gene. J. Biol. Chem. 265:1990;1465-1469.
47. Pontoglio M., Faust D.M., Doyen A., Yaniv M., Weiss M. Hepatocyte nuclear factor 1a gene activation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene. Mol. Cell. Biol. 17:1997;4948-4956.
48. Raymondjean M., Pichard A.-L., Gregori C., Ginot F., Kahn A. Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter. Nucl. Acids. Res. 19:1991;6145-6153.
49. Rey-Campos, J., Chouard, T., Yaniv, M., Cereghini, S., 1991. VHNF-1 is a homeoprotein that activates transcription and forms heterodimers with HNF-1, EMBO J. 1445-1447.
50. Roder K., Wolf S.S., Beck K.F., Sickinger S., Schweizer M. NF-Y binds to the inverted CCAAT box, an essential element for cAMP-dependent regulation of the rat fatty acid synthase (FAS) gene. Gene. 184:1997;21-26.
51. Scofield M.A., Liu F., Abel P.W., Jeffries W.B. Measurement of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 275:1995;1035-1042.
52. Serup P., Petersen H.V., Pedersen E.E., Edlund H., Leonard J., Petersen J.S., Larsson L.I., Madsen O.D. The homeodomain protein IPF 1/STF 1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix loop helix factor binding site. Biochem. J. 310:1995;997-1003.
53. Serup P., Jensen J., Andersen F.G., Jorgensen M.C., Blume N., Holst J.J., Madsen O.D. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor-1. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9015-9020.
54. Sinha S., Maity S.N., Lu J., DeCrombrugghe B. Recombinant rat CBF-C, the third subunit of the CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1624-1628.
55. Tronche F., Rollier A., Sourdive D., Cereghini S., Yaniv M. NFY or a related CCAAT binding factor can be replaced by other transcriptional activators for co-operation with HNF-1 in driving the rat albumin promoter in vivo. J. Mol. Biol. 222:1991;31-43.
56. Vallejo M., Penchuk L., Habener J.F. Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl 1 like, and alpha CBF like transcription factors. J. Biol. Chem. 267:1992;12876-12884.
57. Van Mansfeld A., Mosselman S., Hoppener J., Zandberg J., Van Teeffelen H., Bass P., Lips C., Jansz H. Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man. Biochim. Biophys. Acta. 1087:1990;235-240.
58. Vierra C.A., Nelson C. The Pan basic helix loop helix proteins are required for insulin gene expression. Mol. Endocrinol. 9:1995;64-71.
59. Wang M., Drucker D. Activation of amylin gene transcription by the LIM domain homeobox gene Isl-1. Mol. Endocrinol. 10:1996;243-251.
60. Wang Z.L., Bennet W.M., Ghatei M.A., Byfield P.G., Smith D.M., Bloom S.R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perfused rat islets. Diabetes. 42:1993;330-335.
61. Watada H., Kajimoto Y., Kaneto H., Matsuoka T., Fujitani Y., Miyazaki J., Yamasaki Y. Involvement of the homeodomain containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem. Biophys. Res. Commun. 229:1996;746-751.
62. Yamagata K., Oda N., Kaisaki P., Menzel S., Furuta H., Vaxillaire M., Southam L., Cox R., Lathrop G., Boriraj V., Chen X., Cox N., Oda Y., Yano H., LeBeau M., Yamada S., Nishigori H., Takeda J., Fajans S., Hattersley A., Iwasaki N., Hansen T., Pedersen O., Polonsky K., Turner R., Velho G., Chevre J., Froguel P., Bell G. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature. 384:1996;455-458.